[
  {
    "ts": "2026-02-03T00:28:39+00:00",
    "headline": "AbbVie Inc. (ABBV): A Bull Case Theory",
    "summary": "We came across a bullish thesis on AbbVie Inc. on Disruptive Analytics ’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc.’s share was trading at $223.01 as of January 30th. ABBV’s trailing and forward P/E were 166.99 and 15.70 respectively according to Yahoo Finance. AbbVie Inc., a research-based biopharmaceutical […]",
    "url": "https://finance.yahoo.com/news/abbvie-inc-abbv-bull-case-002839053.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "82b2f111-0e2b-3561-aa17-7d6f819c0cbc",
      "content": {
        "id": "82b2f111-0e2b-3561-aa17-7d6f819c0cbc",
        "contentType": "STORY",
        "title": "AbbVie Inc. (ABBV): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on AbbVie Inc. on Disruptive Analytics ’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc.’s share was trading at $223.01 as of January 30th. ABBV’s trailing and forward P/E were 166.99 and 15.70 respectively according to Yahoo Finance. AbbVie Inc., a research-based biopharmaceutical […]",
        "pubDate": "2026-02-03T00:28:39Z",
        "displayTime": "2026-02-03T00:28:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/bf237822140c1302e609023ce2a6f380",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Illumina (ILMN) Jumps 24.8% on Earnings Beat",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OE0ujLJio14.jBs9jRi30Q--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/bf237822140c1302e609023ce2a6f380.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R8sCU_yA_1.vxb1zEct.eg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bf237822140c1302e609023ce2a6f380.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-inc-abbv-bull-case-002839053.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-inc-abbv-bull-case-002839053.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]